New Novel Metastatic Treatment for Metastatic patients

TSCAN Therapeutics is currently screening patients in 12 sites for their clinical trial.

Check out their website, www.tscan.com for information on their sites open for prescreening as well as their treatment protocol.

You can learn more about the uveal melanoma specific trials at the links below: NCT05812027 (screening protocol) and NCT05973487 (treatment protocol).